Leaders in Risk Management

The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.

In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.

Education & Training

DSRU offers a comprehensive range of education and training courses. Find out more or view our complete course calendar.

News News RSS

BMJ feature on DSRU’s Brexit Forum

Nigel Hawkes’ feature in the BMJ (http://www.bmj.com/content/357/bmj.j2168 published 17th May 2017) outlines some of the concerns raised at the DSRU’s Forum on UK Pharmacovigilance post-Brexit, which was held in London on 26th April. He notes that while the European Medicines Agency (EMA) would have to be relocated in order to remain within the EU, UK pharmacovigilance specialists faced an uncertain future. DSRU Director, Saad Shakir, highlighted the need to avoid overlooking pharmacovigilance and medicines regulation amongst the many other niche areas where Brexit decisions need to be made by the government.

(more…)

View our latest news

Did you know that we can conduct PASS studies in secondary care using our SCEM methodology? Watch this short video to find out how it works:



Our Work - Your Questions

Moving into a career in Pharmacovigilance

The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]

View all our latest questions